.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Spotlight

In-person and virtual events just for HCPs

SpecialtySee All >

Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer

Advertise
About OncLive
Editorial Board
MJH Life Sciences brands
Contact Us
Privacy
Terms & Conditions
Do Not Sell My Information

2 Clarke Drive
Suite 100
Cranbury, NJ 08512

A Practical Approach to the Treatment of Metastatic CRC

EP. 1: Considering the Basics in Newly Diagnosed mCRC

March 29th 2019

EP. 2: Tissue-Based Testing Versus Liquid Biopsy in mCRC

March 29th 2019

EP. 3: Multidisciplinary Approach to Resection in mCRC

March 29th 2019

EP. 4: Sequencing for BRAF+, RAS+, HER2- Left-Sided CRC

March 29th 2019

EP. 5: The Influx of Younger Patients With Advanced CRC

March 29th 2019

EP. 6: Puzzling Together the Pieces in mCRC

March 29th 2019

EP. 7: Adjusting the Lines of Therapy Indication in mCRC

March 29th 2019

EP. 8: Optimizing Dosing in Patients With mCRC

March 29th 2019

EP. 9: Dosing Strategies and Patient Support in mCRC

March 29th 2019

EP. 10: Improving Responsiveness With Immunotherapy in mCRC

March 29th 2019

EP. 11: Refinement of Techniques and the Future of mCRC

March 29th 2019